---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-028494"
form_type: "8-K"
ticker: "MLAB"
cik: "0000724004"
company_name: "MESA LABORATORIES INC /CO/"
filed_at: "2023-10-18T23:59:59+00:00"
generated_at: "2026-06-09T22:10:47.700401+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Mesa Labs completes acquisition of GKE for €85M; expects €19-20M revenue add

## Summary
- Acquired GKE sterilization indicators business, SAL GmbH, and agreed to buy GKE China for €85M total.
- Financed with $65M from credit facility and $12.6M cash; GKE China close expected in Q3 FY2024.
- First 12 months of complete ownership expected to add €19-20M revenue with mid-single-digit organic growth.
- Adjusted operating income margin expected to approach 37%-40% for the first 12 months.
- Combined SDC division has over 200 distribution partners in 80+ countries.

## SEC filing metadata
- accession: 0001437749-23-028494
- form_type: 8-K
- ticker: MLAB
- cik: 0000724004
- company_name: MESA LABORATORIES INC /CO/
- filed_at: 2023-10-18T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/724004/000143774923028494/0001437749-23-028494-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/724004/000143774923028494/mlab20231018_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-028494
- JSON: https://secwatch.observer/filing/0001437749-23-028494.json
- Plain text: https://secwatch.observer/filing/0001437749-23-028494.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.